Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Purple Biotech American Depositary Shares Representing 200 Ord Shs PPBT

Healthcare
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi... see more

Recent & Breaking News (NDAQ:PPBT)

Kitov Enters Immuno-Oncology Field Through Acquisition of TyrNovo

PR Newswire January 12, 2017

Kitov Successfully Completes All KIT-302 Testing Required for New Drug Application to U.S. FDA

PR Newswire December 7, 2016

Mid-Afternoon Market Update: Dow Rises Over 100 Points; SYNNEX Shares Climb On Earnings Beat

Benzinga.com  September 27, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  September 27, 2016

Mid-Day Market Update: Crude Oil Down 3.5%; EndoChoice Shares Jump Following Boston Scientific Deal

Benzinga.com  September 27, 2016

Kitov Reports Successful Results for Additional KIT-302 Pharmacokinetic Bioequivalence Study

PR Newswire September 27, 2016

Kitov Pharmaceuticals Issues First Half 2016 Financial Reports

PR Newswire August 17, 2016

7 Biggest Mid-Day Losers For Wednesday

Benzinga.com  June 29, 2016

Kitov Pharmaceuticals Announces Pricing of $12 Million Follow-On Public Offering in the U.S.A.

PR Newswire June 29, 2016

Kitov's Lead Drug KIT-302 Achieves Manufacturing Milestone Ahead of Planned NDA Filing with U.S. FDA

PR Newswire June 28, 2016

Kitov Reports New Data Demonstrating KIT-302 Has Beneficial Effects on Kidney Function

PR Newswire June 24, 2016

New Colombia Resources Inc. Optimistic About Colombia's Cease Fire with the FARC after 52 Years of Fighting as a Beginning to a New Colombia

PR Newswire June 24, 2016

Kitov Announces Completion of Manufacturing Pivotal Batches of KIT-302 Required for Registration in the U.S.

PR Newswire May 27, 2016